Since early May, and as of 11 October 2022, 20 455 confirmed cases of monkeypox (MPX) have been reported from 29 European Union/European Economic Area (EU/EEA) countries, including four deaths. As of 30 September, MPX confirmed cases reported from EU/EEA countries represented almost one third (29.7%) of the cases reported to the World Health Organization (WHO) globally (68 267 cases).
Since early May 2022 and as of 7 July, cases of monkeypox (MPX) have been reported in non-endemic countries. Twenty-six European Union/European Economic Area (EU/EEA) countries have reported 4 908 cases, representing 65% of all cases reported worldwide in 2022.
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
The risks assessed in this document are of the introduction and further spread of monkeypox in the EU/EEA, infection with regards to different settings (e.g. healthcare, community, etc.) and transmission through SoHO.